Sign in
Taking peopleNo phase

Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy

Key facts

Who runs it
University Hospital, Tours
Where
France35 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,078 people, planned
Started
30 Nov 2025
Expected to end
Oct 2034
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Prone position
Record updated
4 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Adult patients admitted to an intensive care unit or intermediate care unit
  • Suspicion of community acquired pneumonia (at least one of the 3 criteria): fever, cough, purulent expectoration
  • And abnormalities suggestive of pneumonia by chest X-ray or CT-scan
  • PaO2/FiO2 ratio <300 mmHg (or equivalent SpO2/FiO2 i.e. < 315 mmHg) under a minimum gas flow of 30 L/min
  • Person affiliated to a French social security system or equivalent
  • Informed consent

Who cannot take part

  • More than 8h awake prone positioning prior to inclusion
  • Patients with formal indication for non-invasive ventilation: exacerbation of chronic obstructive pulmonary disease, acute cardiogenic pulmonary oedema
  • Positive SARS-COV2 test within the last 30 days
  • Indication for immediate intubation
  • Patients for whom a "do not intubate" decision has been made
  • Chest trauma or other contraindication to prone position
  • Pregnant or breastfeeding woman
  • Subjects who are under legal protection measure
  • More than 48h since intensive care unit or intermediate care unit admission

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Community acquired pneumonia, in particular when requiring oxygen therapy because of acute hypoxemic respiratory failure and meeting acute respiratory distress syndrome (ARDS) criteria frequently leads to tracheal intubation and poor outcome.

Read full original descriptionShow less

Among invasively mechanically ventilated patients with ARDS and presenting a PaO2/FiO2 ratio (arterial partial pressure of oxygen to inspired fraction of oxygen) of less than 150 mmHg, the prone position significantly reduces mortality and represents standard care (Guérin 2013). Among non-intubated COVID-19 patients, a subtype of viral community acquired pneumonia, a recent study showed that awake prone positioning reduces the composite outcome of intubation or death among patients requiring nasal high flow therapy. Furthermore, it favored weaning of nasal high flow therapy.

Prone position in patients with non-COVID ARDS treated with high nasal flow was evaluated in 20 patients with predominantly viral pneumonia (Ding 2020) and was associated with improved oxygenation.

Coordinating investigator hypothesize that prone positioning of patients suffering non-COVID community acquired pneumonia and undergoing nasal high flow therapy can significantly improve outcome by reducing the need for intubation and associated therapies such as sedation and muscle relaxation.

The 2 groups in the trial

  • Prone position groupTreatment being tested

    patients will be invited and assisted to prone as long as possible every day. The goal is to achieve at least 8h in the prone position per 24h period, with 3-6 prone sessions.

    Treatment: Prone position

  • Control groupNo study treatment, for comparison

    Usual care including nasal high flow therapy adapted for a SpO2 of 92-95%. No prone positioning.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy, Excluding COVID-19
Record updated
4 May 2026